Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis

Lung Cancer

Volumn 88, Issue 1, 2015, Pages 80-84

  Steuer, Conor E ^a   Behera, Madhusmita ^a   Kim, Sungjin ^a   Patel, Nikita ^a   Chen, Zhengjia ^a   Pillai, Rathi ^a   Saba, Nabil F ^a   Shin, Dong M ^a   Owonikoko, Taofeek K ^a   Khuri, Fadlo R ^a   Ramalingam, Suresh S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer; Outcomes; Thromboembolism; Utilization; VTE

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER STAGING; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISABILITY SEVERITY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HOSPITAL CHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM; AGE DISTRIBUTION; AGED; FACTUAL DATABASE; LUNG NEOPLASMS; MORTALITY; SEX RATIO; TREATMENT OUTCOME;

AGE DISTRIBUTION; AGED; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INPATIENTS; LENGTH OF STAY; LUNG NEOPLASMS; MALE; SEX DISTRIBUTION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84924424639     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.01.022     Document Type: Article

References (26)

1. Sallah S., Wan J.Y., Nguyen N.P. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002, 87(4):575-579.
2. Prandoni P., Falanga A., Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005, 6(6):401-410.
3. Khorana A.A., Kuderer N.M., Culakova E., Lyman G.H., Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008, 111(10):4902-4907.
4. Khorana A.A., Francis C.W., Culakova E., Lyman G.H. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 2005, 104(12):2822-2829.
5. Lee A.Y., Levine M.N. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003, 107(23 Suppl. 1):I17-I21.
6. Kröger K., Weiland D., Ose C., Neumann N., Weiss S., Hirsch C., et al. Risk factors for venous thromboembolic events in cancer patients. Ann Oncol 2006, 17(2):297-303.
7. Walker A.J., Card T.R., West J., Crooks C., Grainge M.J. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked united kingdom databases. Eur J Cancer 2013, 49(6):1404-1413.
8. Connolly G.C., Menapace L., Safadjou S., Francis C.W., Khorana A.A. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients. Clin Lung Cancer 2013, 14(6):713-718.
9. Chew H.K., Davies A.M., Wun T., Harvey D., Zhou H., White R.H. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 2008, 6(4):601-608.
10. Huang H., Korn J.R., Mallick R., Friedman M., Nichols C., Menzin J. Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study. J Thromb Thrombolysis 2012, 34(4):446-456.
11. Park E.R., Japuntich S.J., Rigotti N.A., Traeger L., He Y., Wallace R.B., et al. A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer 2012, 118(12):3153-3164.
12. Agency for Healthcare Research and Quality (AHRQ): Nationwide Inpatient Sample (NIS): Healthcare Cost and Utilization Project (HCUP), 2006-2010. AHRQ, Rockville, MD. Accessed 16.02.14. http://www.hcup-us.ahrq.gov/nisoverview.jsp.
13. Qureshi A.I., Chaudhry S.A., Hassan A.E., Zacharatos H., Rodriguez G.J., Suri M.F., et al. Thrombolytic treatment of patients with acute ischemic stroke related to underlying arterial dissection in the united states. Arch Neurol 2011, 68(12):1536-1542.
14. Maiser S., Adil M.M., Roohani P., Tariq N. Patients with transverse myelitis who developed venous thromboembolism while hospitalized have increased rate for inpatient mortality. J Neuroimmunol 2013, 261(1-2):120-122.
15. http://www.cancer.gov/cancertopics/types/lung.
16. Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005, 293(6):715-722.
17. Lee Y.G., Kim I., Lee E., Bang S.M., Kang C.H., Kim Y.T., et al. Risk factors and prognostic impact of venous thromboembolism in asian patients with non-small cell lung cancer. Thromb Haemost 2014, 111:6.
18. Blom J.W., Osanto S., Rosendaal F.R. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2004, 2(10):1760-1765.
19. White R.H., Zhou H., Romano P.S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in california. Ann Intern Med 1998, 128(9):737-740.
20. Zakai N.A., McClure L.A. Racial differences in venous thromboembolism. J Thromb Haemost 2011, 9(10):1877-1882.
21. Zhang J., Zhang Y.L., Ma K.X., Qu J.M. Efficacy and safety of adjunctive anticoagulation in patients with lung cancer without indication for anticoagulants: a systematic review and meta-analysis. Thorax 2013, 68(5):442-450.
22. van Herk-Sukel M.P., Shantakumar S., Penning-van Beest F.J., Kamphuisen P.W., Majoor C.J., Overbeek L.I., et al. Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal study. Lung 2013, 191(5):501-509.
23. Connolly G.C., Dalal M., Lin J., Khorana A.A. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer. Lung Cancer 2012, 78(3):253-258.
24. Griffiths G.O., Burns S., Noble S.I., Macbeth F.R., Cohen D., Maughan T.S., Fragmatic: A randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer. BMC Cancer 2009, 9:355.
25. Agnelli G., George D.J., Kakkar A.K., Fisher W., Lassen M.R., Mismetti P., et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 2012, 366(7):601-609.
26. Young A.M., Billingham L.J., Begum G., Kerr D.J., Hughes A.I., Rea D.W., et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 2009, 373(9663):567-574.